Our group focuses on improving the understanding of biological pathways and pathogenic mechanisms behind rare and common immune diseases, especially primary immune deficiencies and multiple sclerosis, and utilizing the new knowledge to the benefit of the patients. We use rare immune diseases as models for autoimmunity, and focus on identifying novel causative genes for the rare disorders in the founder population of Finns and study the functional consequences of the identified gene defects.